Replies to post #213 on Entest Group Inc (ETNI)

[ronrooster]

Half of something is better than 100% of nothing.

[JokersWild12]

It would be interesting to know why this drug delivery method was selected and is worth revenue sharing at 50% versus another standard method that would not require that. The Development Agreement looks like it needs to be updated to the new company name of Dyve Biosciences from the prior name of Ampersand Biopharma. GL.